Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

Overview
This analysis includes a discussion of Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS) devices, technological innovations, competitors, trends, and expected market growth. Market analysis includes 5-year market forecasts by segment and region, market drivers/limiters, estimated market share by region, and corporate strategies for success in the burgeoning market of neuromodulation.

Key Questions Answered

• What is the value of the global DBS and VNS devices markets? What is the expected growth for each segment over the next 5 years?


• What is the expected market growth by major region of the world (US, 5EU, Japan, and RoW)?


• What are key drivers & limiters?


• Technological innovations & trends? What are noninvasive brain stimulation technologies?


• Who are the leading competitors, estimated market share by region, and strategic growth strategies? Emerging start-ups?

Report Highlights

• The DBS & VNS device segments contributed nearly one-quarter of the $4bn global neuromodulation market in 2017.


• These segments were valued at more than $1bn in combined revenues in 2017 with expected growth of more than 10% over the next 5 years.


• The US remains the largest market, accounting for nearly 65-85% of sales in 2017, although regions outside the US represent good growth potential.


• The markets will be driven by the aging population at high risk of incurable, neurodegenerative diseases/disorders (such as Parkinson’s disease/tremor and epilepsy), good US reimbursement for severe, drug-refractive patients, increasing adoption of DBS/VNS therapies by a skilled surgeon network, as well as fast-paced technological innovation creating safer, more precise neurostimulation that lessens debilitating symptoms, reduces side effects and improves quality of life.